Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06075576 · ClinicalTrials.gov registry record
Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 23
- Enrollment target
NCT06075576: Completed study, sponsored by Johnson & Johnson Vision Care.
NCT06075576 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06075576 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This is a 3-visit, single site, observational clinical study to evaluate the characterization of the central and peripheral wavefront aberration profiles in pediatric myopic subjects.
Primary Outcome
Assessment of central aberration profile of pediatric myopia population under cycloplegic conditions for distance (target at 4m) viewing conditions.
Interventions
- DIAGNOSTIC_TEST Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2025-08-11 |
What the finished NCT06075576 record still lists
NCT06075576 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT06075576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06075576 about?
NCT06075576 is a clinical study titled "Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects". This is a 3-visit, single site, observational clinical study to evaluate the characterization of the central and peripheral wavefront aberration profiles in pediatric myopic subjects.
What is the current status of trial NCT06075576?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2023-11-16. Estimated completion is 2025-08-11.
What interventions are being tested in trial NCT06075576?
The interventions under investigation include: Intervention (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06075576?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI